Recent developments

at Tullis and our portfolio companies

News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

October

8

Alphatec Pops 21% On 3Q Sales Guidance Beat; Street Says Buy

The Strong Buy analyst consensus boasts 5 unanimous Buy ratings. Alphatec (ATEC) expects third-quarter...

7

ATEC Announces Preliminary Third Quarter 2020 Financial Results

Third quarter U.S. revenue expected to grow over 40% Eighth consecutive quarter of double-digit revenue growth Revenue per case expands on strong pull- through from SafeOp neuromonitoring and new...

6

ATEC Announces Commercial Release Of Distinct, Comprehensive TLIF Approach

Sigma TLIF Access System, InVictus Modular Fixation System, and SafeOp Neural InformatiX System Clinically Differentiate the...

5

ATEC Announces Novel PTP Approach

Over 500 initial surgeries successfully performed Advances lateral surgery with a more predictable, more...

1

electroCore, Inc. Announces Extension of NHS England’s Innovation and Technology Payment (ITP) Program to Fund Continued Use of gammaCore™ in England

ITP program providing reimbursement for gammaCore™ extended to March. 31, 2021 with option for additional...

29

TriSalus Life Sciences Appoints Steven Katz, M.D., Chief Medical Officer

Renowned surgeon, clinician, and researcher to advance work to combine novel immuno-oncology therapies with...

29

Exagen Inc. Announces Agreement with Provider Network of America

Expanding Access for AVISE® Tests to 8 Million Members SAN DIEGO, Sept. 29, 2020 (GLOBE NEWSWIRE)...

24

electroCore Announces Agreement with UpScript, LLC to be Exclusive Online Telehealth Provider for gammaCore Sapphire™ CV

Comprehensive telehealth platform to facilitate the efficient procurement of gammaCore Sapphire™ CV (non-invasive vagus...

23

Exagen Appoints Wendy Johnson to Board of Directors

Additional independent board member will also serve on Audit Committee SAN DIEGO, Sept. 23, 2020 (GLOBE...

23

TriSalus Life Sciences Lays Out Therapeutic Strategy Upon Acquisition of First Therapeutic Candidate

Initiating clinical trials to evaluate investigational toll-like receptor 9 agonist, SD-101, in patients with...

21

Exagen Launches Test to Aid in the Detection of ANCA-Associated Vasculitis (AAV)

SAN DIEGO, Sept. 21, 2020 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the...

27

electroCore Announces Publication in Brain Stimulation Highlighting Non-Invasive Vagal Nerve Stimulation’s (nVNS) Potential Role in Treatment of Post-Traumatic Stress Disorder (PTSD)

Double-blind sham-controlled study of nineteen participants who had experienced trauma but did not have...

Recent developments

News

October

8

Alphatec Pops 21% On 3Q Sales Guidance Beat; Street Says Buy

October

7

ATEC Announces Preliminary Third Quarter 2020 Financial Results

October

6

ATEC Announces Commercial Release Of Distinct, Comprehensive TLIF Approach

October

5

ATEC Announces Novel PTP Approach

October

1

electroCore, Inc. Announces Extension of NHS England’s Innovation and Technology Payment (ITP) Program to Fund Continued Use of gammaCore™ in England

September

29

TriSalus Life Sciences Appoints Steven Katz, M.D., Chief Medical Officer

September

29

Exagen Inc. Announces Agreement with Provider Network of America

September

24

electroCore Announces Agreement with UpScript, LLC to be Exclusive Online Telehealth Provider for gammaCore Sapphire™ CV

September

23

Exagen Appoints Wendy Johnson to Board of Directors

September

23

TriSalus Life Sciences Lays Out Therapeutic Strategy Upon Acquisition of First Therapeutic Candidate

September

21

Exagen Launches Test to Aid in the Detection of ANCA-Associated Vasculitis (AAV)

August

27

electroCore Announces Publication in Brain Stimulation Highlighting Non-Invasive Vagal Nerve Stimulation’s (nVNS) Potential Role in Treatment of Post-Traumatic Stress Disorder (PTSD)